Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W3086493405', 'doi': 'https://doi.org/10.1111/ajco.13459', 'title': 'Updates to the drug‐resistant mechanism of proteasome inhibitors in multiple myeloma', 'display_name': 'Updates to the drug‐resistant mechanism of proteasome inhibitors in multiple myeloma', 'publication_year': 2020, 'publication_date': '2020-09-13', 'ids': {'openalex': 'https://openalex.org/W3086493405', 'doi': 'https://doi.org/10.1111/ajco.13459', 'mag': '3086493405', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/32920949'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/ajco.13459', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajco.13459', 'source': {'id': 'https://openalex.org/S77500791', 'display_name': 'Asia-Pacific Journal of Clinical Oncology', 'issn_l': '1743-7555', 'issn': ['1743-7555', '1743-7563'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajco.13459', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5070102664', 'display_name': 'Yang Bai', 'orcid': 'https://orcid.org/0000-0003-0415-8262'}, 'institutions': [{'id': 'https://openalex.org/I4210125137', 'display_name': 'First Hospital of Jilin University', 'ror': 'https://ror.org/034haf133', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210125137']}, {'id': 'https://openalex.org/I194450716', 'display_name': 'Jilin University', 'ror': 'https://ror.org/00js3aw79', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I194450716']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Yang Bai', 'raw_affiliation_strings': ['Department of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021 P. R. China'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021 P. R. China', 'institution_ids': ['https://openalex.org/I4210125137', 'https://openalex.org/I194450716']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5100666645', 'display_name': 'Xing Su', 'orcid': 'https://orcid.org/0000-0001-7516-0250'}, 'institutions': [{'id': 'https://openalex.org/I194450716', 'display_name': 'Jilin University', 'ror': 'https://ror.org/00js3aw79', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I194450716']}, {'id': 'https://openalex.org/I4210125137', 'display_name': 'First Hospital of Jilin University', 'ror': 'https://ror.org/034haf133', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210125137']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Xing Su', 'raw_affiliation_strings': ['The Laboratory of Cancer Precision Medicine, The First Hospital of Jilin University, Changchun, 130021 P. R. China'], 'affiliations': [{'raw_affiliation_string': 'The Laboratory of Cancer Precision Medicine, The First Hospital of Jilin University, Changchun, 130021 P. R. China', 'institution_ids': ['https://openalex.org/I194450716', 'https://openalex.org/I4210125137']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5100666645'], 'corresponding_institution_ids': ['https://openalex.org/I194450716', 'https://openalex.org/I4210125137'], 'apc_list': {'value': 3350, 'currency': 'USD', 'value_usd': 3350, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.651, 'has_fulltext': False, 'cited_by_count': 16, 'citation_normalized_percentile': {'value': 0.310319, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 91, 'max': 92}, 'biblio': {'volume': '17', 'issue': '1', 'first_page': '29', 'last_page': '35'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10649', 'display_name': 'Diagnosis and Treatment of Multiple Myeloma', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10649', 'display_name': 'Diagnosis and Treatment of Multiple Myeloma', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin-Proteasome Proteolytic Pathway', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Targeted Protein Degradation in Biomedical Research', 'score': 0.9985, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/drug-class', 'display_name': 'Drug class', 'score': 0.70164555}, {'id': 'https://openalex.org/keywords/proteasome-inhibitors', 'display_name': 'Proteasome Inhibitors', 'score': 0.590972}, {'id': 'https://openalex.org/keywords/proteasome', 'display_name': 'Proteasome', 'score': 0.555113}, {'id': 'https://openalex.org/keywords/pathogenesis', 'display_name': 'Pathogenesis', 'score': 0.5225172}, {'id': 'https://openalex.org/keywords/international-myeloma-working-group', 'display_name': 'International Myeloma Working Group', 'score': 0.521903}, {'id': 'https://openalex.org/keywords/refractory', 'display_name': 'Refractory (planetary science)', 'score': 0.48516852}, {'id': 'https://openalex.org/keywords/anticancer-drug', 'display_name': 'Anticancer drug', 'score': 0.4305303}], 'concepts': [{'id': 'https://openalex.org/C2777478702', 'wikidata': 'https://www.wikidata.org/wiki/Q419319', 'display_name': 'Bortezomib', 'level': 3, 'score': 0.8961763}, {'id': 'https://openalex.org/C27740335', 'wikidata': 'https://www.wikidata.org/wiki/Q14878333', 'display_name': 'Proteasome', 'level': 2, 'score': 0.80716854}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.76805544}, {'id': 'https://openalex.org/C2778176773', 'wikidata': 'https://www.wikidata.org/wiki/Q2976049', 'display_name': 'Drug class', 'level': 3, 'score': 0.70164555}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.6601649}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.65322286}, {'id': 'https://openalex.org/C114851261', 'wikidata': 'https://www.wikidata.org/wiki/Q12147416', 'display_name': 'Drug resistance', 'level': 2, 'score': 0.5978253}, {'id': 'https://openalex.org/C2778367456', 'wikidata': 'https://www.wikidata.org/wiki/Q7251235', 'display_name': 'Proteasome inhibitor', 'level': 3, 'score': 0.5942719}, {'id': 'https://openalex.org/C89611455', 'wikidata': 'https://www.wikidata.org/wiki/Q6804646', 'display_name': 'Mechanism (biology)', 'level': 2, 'score': 0.5414756}, {'id': 'https://openalex.org/C2780942790', 'wikidata': 'https://www.wikidata.org/wiki/Q372016', 'display_name': 'Pathogenesis', 'level': 2, 'score': 0.5225172}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.48592272}, {'id': 'https://openalex.org/C142424586', 'wikidata': 'https://www.wikidata.org/wiki/Q7307572', 'display_name': 'Refractory (planetary science)', 'level': 2, 'score': 0.48516852}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.45805892}, {'id': 'https://openalex.org/C3018890749', 'wikidata': 'https://www.wikidata.org/wiki/Q204711', 'display_name': 'Food and drug administration', 'level': 2, 'score': 0.44115826}, {'id': 'https://openalex.org/C3018146709', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Anticancer drug', 'level': 3, 'score': 0.4305303}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.41304705}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.39426017}, {'id': 'https://openalex.org/C60644358', 'wikidata': 'https://www.wikidata.org/wiki/Q128570', 'display_name': 'Bioinformatics', 'level': 1, 'score': 0.3353126}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.2888703}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.15630853}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.06137225}, {'id': 'https://openalex.org/C138885662', 'wikidata': 'https://www.wikidata.org/wiki/Q5891', 'display_name': 'Philosophy', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C111472728', 'wikidata': 'https://www.wikidata.org/wiki/Q9471', 'display_name': 'Epistemology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C87355193', 'wikidata': 'https://www.wikidata.org/wiki/Q411', 'display_name': 'Astrobiology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': True}, {'descriptor_ui': 'D061988', 'descriptor_name': 'Proteasome Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000069286', 'descriptor_name': 'Bortezomib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069286', 'descriptor_name': 'Bortezomib', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D046988', 'descriptor_name': 'Proteasome Endopeptidase Complex', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D046988', 'descriptor_name': 'Proteasome Endopeptidase Complex', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D061988', 'descriptor_name': 'Proteasome Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/ajco.13459', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajco.13459', 'source': {'id': 'https://openalex.org/S77500791', 'display_name': 'Asia-Pacific Journal of Clinical Oncology', 'issn_l': '1743-7555', 'issn': ['1743-7555', '1743-7563'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/32920949', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/ajco.13459', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajco.13459', 'source': {'id': 'https://openalex.org/S77500791', 'display_name': 'Asia-Pacific Journal of Clinical Oncology', 'issn_l': '1743-7555', 'issn': ['1743-7555', '1743-7563'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.67}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 67, 'referenced_works': ['https://openalex.org/W1570023087', 'https://openalex.org/W1845237317', 'https://openalex.org/W1858051302', 'https://openalex.org/W1869200070', 'https://openalex.org/W1980181091', 'https://openalex.org/W2008743974', 'https://openalex.org/W2029501972', 'https://openalex.org/W2039856481', 'https://openalex.org/W2084156359', 'https://openalex.org/W2137941402', 'https://openalex.org/W2175072810', 'https://openalex.org/W2283862988', 'https://openalex.org/W2343868954', 'https://openalex.org/W2496772221', 'https://openalex.org/W2517106444', 'https://openalex.org/W2517817589', 'https://openalex.org/W2520638688', 'https://openalex.org/W2528869567', 'https://openalex.org/W2566193100', 'https://openalex.org/W2566788322', 'https://openalex.org/W2569372699', 'https://openalex.org/W2593445153', 'https://openalex.org/W2614174209', 'https://openalex.org/W2622381363', 'https://openalex.org/W2731995447', 'https://openalex.org/W2744373774', 'https://openalex.org/W2751037830', 'https://openalex.org/W2759270106', 'https://openalex.org/W2784022040', 'https://openalex.org/W2792326760', 'https://openalex.org/W2798011605', 'https://openalex.org/W2801061698', 'https://openalex.org/W2803679599', 'https://openalex.org/W2806104868', 'https://openalex.org/W2883591936', 'https://openalex.org/W2885967791', 'https://openalex.org/W2887022567', 'https://openalex.org/W2887253292', 'https://openalex.org/W2897241170', 'https://openalex.org/W2900253954', 'https://openalex.org/W2900464803', 'https://openalex.org/W2901300056', 'https://openalex.org/W2910809275', 'https://openalex.org/W2914157523', 'https://openalex.org/W2914294305', 'https://openalex.org/W2918457729', 'https://openalex.org/W2921123848', 'https://openalex.org/W2932874393', 'https://openalex.org/W2935332994', 'https://openalex.org/W2937191569', 'https://openalex.org/W2945036043', 'https://openalex.org/W2962995528', 'https://openalex.org/W2963854884', 'https://openalex.org/W2966402818', 'https://openalex.org/W2966984447', 'https://openalex.org/W2975343753', 'https://openalex.org/W2982867448', 'https://openalex.org/W2984347539', 'https://openalex.org/W2990940920', 'https://openalex.org/W2993536872', 'https://openalex.org/W2999431721', 'https://openalex.org/W3002758256', 'https://openalex.org/W3009651304', 'https://openalex.org/W3021442771', 'https://openalex.org/W3022621507', 'https://openalex.org/W3033129714', 'https://openalex.org/W4211058750'], 'related_works': ['https://openalex.org/W4300495055', 'https://openalex.org/W4281831295', 'https://openalex.org/W3146265467', 'https://openalex.org/W3032840474', 'https://openalex.org/W3032571198', 'https://openalex.org/W3029266790', 'https://openalex.org/W2321752808', 'https://openalex.org/W2053506257', 'https://openalex.org/W1973074169', 'https://openalex.org/W1732928399'], 'abstract_inverted_index': {'Abstract': [0], 'Proteasome': [1], 'inhibitors': [2], '(PIs)': [3], 'have': [4], 'been': [5], 'a': [6, 79, 89], 'kind': [7], 'of': [8, 46, 49, 64, 76, 92], 'backbone': [9], 'therapies': [10], 'for': [11], 'newly': [12], 'diagnosed': [13], 'as': [14, 16], 'well': [15], 'relapsed': [17], 'or': [18], 'refractory': [19], 'myeloma': [20], 'patients': [21], 'in': [22, 41, 61, 70, 82, 98], 'the': [23, 28, 34, 54, 62, 65, 74, 93], 'last': [24], 'two': [25], 'decades.': [26], 'Bortezomib,': [27], 'first‐in‐class': [29], 'PI,': [30], 'was': [31], 'approved': [32], 'by': [33], 'United': [35], 'States': [36], 'Food': [37], 'and': [38, 95], 'Drug': [39], 'Administration': [40], '2003.': [42], 'The': [43], 'key': [44], 'roles': [45], 'this': [47], 'class': [48], 'agents': [50], 'are': [51, 59], 'targeting': [52], 'at': [53, 88], 'overstressed': [55], '26S': [56], 'proteasome,': [57], 'which': [58], 'involved': [60, 97], 'pathogenesis': [63], 'disease.': [66], 'Despite': [67], 'recent': [68], 'advancements': [69], 'clinical': [71], 'antimyeloma': [72], 'treatment,': [73], 'acquisition': [75], 'resistance': [77], 'is': [78], 'major': [80], 'limitation': [81], 'PI': [83], 'therapy.': [84], 'This': [85], 'review': [86], 'aims': [87], 'better': [90], 'understanding': [91], 'pathways': [94], 'biomarkers': [96], 'MM': [99], 'drug': [100], 'resistance.': [101]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3086493405', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 6}, {'year': 2022, 'cited_by_count': 3}, {'year': 2021, 'cited_by_count': 6}], 'updated_date': '2024-09-01T01:43:42.563295', 'created_date': '2020-09-21'}